BSE Live
Jan 05, 16:01Prev. Close
410.90
Open Price
410.75
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Jan 05, 15:59Prev. Close
410.95
Open Price
411.50
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
404.95 (70)
| Cash Flow of Aarti Drugs (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 211.77 | 235.53 | 224.18 | 269.96 | 369.01 | |
| Net CashFlow From Operating Activities | 244.58 | 358.92 | 134.20 | 69.64 | 154.85 | |
| Net Cash Used In Investing Activities | -164.63 | -223.65 | -163.97 | -148.86 | -71.68 | |
| Net Cash Used From Financing Activities | -82.12 | -136.03 | 16.54 | 92.03 | -81.13 | |
| Foreign Exchange Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | -2.17 | -0.76 | -13.23 | 12.80 | 2.04 | |
| Cash And Cash Equivalents Begin of Year | 6.74 | 7.50 | 21.61 | 8.81 | 6.77 | |
| Cash And Cash Equivalents End Of Year | 4.58 | 6.74 | 8.38 | 21.61 | 8.81 |
14.11.2025
Aarti Drugs Consolidated September 2025 Net Sales at Rs 652.79 crore, up 9.1% Y-o-Y
12.11.2025
Aarti Drugs Standalone September 2025 Net Sales at Rs 578.95 crore, up 6.6% Y-o-Y
18.07.2025
Aarti Drugs Standalone June 2025 Net Sales at Rs 520.96 crore, up 5.68% Y-o-Y
18.07.2025
Aarti Drugs Consolidated June 2025 Net Sales at Rs 590.51 crore, up 6.33% Y-o-Y